Since the election, most policy pundits have predicted a political shakeup that’s every bit as sweeping as Donald Trump’s November victory. The president-elect’s choices for health-related cabinet ...

BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...

Advancements in drug manufacturing technologies are reshaping global regulatory frameworks. This shift is largely driven by the integration of artificial intelligence (AI)-powered models, cloud-based ...

The pharmaceutical industry is on the cusp of an AI-driven revolution. By 2030, AI-powered drug discovery is projected to be a $9.1 billion market, growing at a staggering 29.7% CAGR. AI promises to ...

Forbes contributors publish independent expert analyses and insights. Gil Press writes about technology, entrepreneurs and innovation. Will AI transform the typical trials and tribulations of drug ...